worldwide offices | stay connected | contact | help | sitemap

 
 

 

 

 

Novartis Newsroom

Novartis Newsroom

Fact sheet 2007

Chairman and CEO Daniel Vasella, M.D.

 

 

Headquarters Basel, Switzerland

 

 

Major R&D sites Basel, Switzerland
  Cambridge, Massachusetts
  East Hanover, New Jersey
  Horsham, England
  Shanghai, China

 

 

Major production sites Basel, Schweizerhalle and Stein, Switzerland
  Grimsby, UK
  Huningue, France
  Kundl and Schaftenau, Austria
  Kurtkoy, Turkey
  Nyon, Switzerland
  Ringaskiddy, Ireland
  Singapore
  Suffern, New York, US

 

 

Web site address www.novartis.com

 

 

Stock exchange listings Switzerland (virt-x)
  New York Stock Exchange
  London Stock Exchange

 

 

2007 sales USD 38.1 billion
Pharmaceuticals USD 24.0 billion
Vaccines and Diagnostics USD 1.5 billion
Sandoz USD 7.2 billion
Consumer Health USD 5.4 billion

 

 

2007 R&D spending USD 6.4 billion
Pharmaceuticals USD 5.1 billion
Vaccines and Diagnostics USD 295 million
Sandoz USD 563 million
Consumer Health USD 301 million
Corporate USD 183 million

 

 

Full-time associates (2007) 98 200
Pharmaceuticals 54 613
Vaccines and Diagnostics 4 810
Sandoz 23 087
Consumer Health 13 956
Corporate 1 734

 

SWX

NYSE

 
 

NOVZn

 
 

NVS

Get Novartis Media Releases through RSS

Stay Connected

Receive updates on company news and announcements.

Novartis milestones

Innovative medicines